NNE Pharmaplan launched as a joint company
NNE Pharmaplan has been officially launched as a joint company following NNE's acquisition of the German engineering company Pharmaplan GmbH which was completed on 31 March 2007. According to the company, Pharmaplan supplements NNE with know-how in delivery of turnkey facilities, validation and key pharmaceutical processes, whereas NNE supplements Pharmaplan in areas such as biotechnology, cleanroom and automation.
"We will now start integrating the two companies, while maintaining focus on the daily business of supplying high-quality engineering and consultancy services to the pharmaceutical and biotechnological industries", says Hans Ole Voigt, President of NNE Pharmaplan. "I am confident that the integration process will be relatively smooth. The purpose of the merger is to utilise the business synergies and future growth potential which will be released by unifying two companies with complementary market presence and competences."
Today, NNE Pharmaplan has five offices in the US market. In the growing markets of India and China the company has 60 employees in offices in Delhi and Bangalore and 130 employees in Tianjin, China. Europe and the rest of Asia are covered by 12 offices, as well as the corporate headquarters in Copenhagen, Denmark, and a significant Germany hub in Frankfurt.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.